Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VATS vs IET for Empyema (VIETS Trial)
NCT07886541Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator, dornase alfa in empyema, pleural infection, sponsored by Amsterdam University Medical Center. Started Oct 2026; status: recruiting.
02
Drugs
tissue-plasminogen activatordornase alfa
03
Conditions
empyemapleural infection
Beyond the preview
Go deeper on NCT07886541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07886541.